Cannabidiol Demonstrates Remarkable Efficacy in Treating Multidrug-Resistant Enterococcus Faecalis Infections In Vitro and In Vivo
DOI:
https://doi.org/10.48048/tis.2024.8150Keywords:
Enterococcus faecalis, Cannabis sativa, Antimicrobial activity, Herbal medicine, Alternative medicine, Anti-biofilm formation, Cannabidiol, PhytochemicalsAbstract
The growing prevalence of multidrug-resistant Enterococcus faecalis infection has become a global concern. There is a demand for alternative antibacterial agents, such as herbal alternatives, such as Cannabidiol, that are cost-effective, non-toxic and efficient. This study investigates the Minimum Inhibitory Concentration (MIC) for planktonic cells and the Minimum Biofilm Eradication Concentration (MBEC) for biofilm formation in multidrug- resistance isolates of E. faecalis isolates, particularly focusing cannabidiol activity. E. faecalis isolates with strong biofilm presence, vancomycin, levofloxacin, and daptomycin displayed high MIC and MBEC values. Cannabidiol exhibited a significantly lower MIC (1 μg/mL) for planktonic cells and a low MBEC (2 μg/mL). Moreover, at low concentrations (2 µg/mL), cannabidiol demonstrated notable reductions in biofilm biovolume, bacterial cell viability and colony-forming unit compared to vancomycin, levofloxacin, and daptomycin. The mice treated with cannabidiol (100 mg/kg) exhibited a significant reduction in E. faecalis bacterial load in internal organs and increased the survival. In conclusion, the findings underscore the promising antibiofilm properties of cannabidiol against E. faecalis, indicating its potential as a novel therapeutic agent.
HIGHLIGHTS
- The increase of multidrug-resistant Enterococcus faecalis infection has become a global concern.
- Cannabidiol (CBD) is an herbal alternative with potential antibacterial activity.
- Our study result shows the promising antibiofilm properties of cannabidiol against E. faecalis in vitro and in vivo.
GRAPHICAL ABSTRACT
Downloads
References
S Na, DL Wannigama and T Saethang. Antimicrobial peptides recognition using weighted physicochemical property encoding. J. Bioinformatics Comput. Biol. 2023; 21, 2350006.
AMS Shein, DL Wannigama, C Hurst, PN Monk, M Amarasiri, VN Badavath, P Phattharapornjaroen, WGF Ditcham, P Ounjai, T Saethang, N Chantaravisoot, W Thuptimdang, S Luk-In, S Nilgate, U Rirerm, C Tanasatitchai, N Kueakulpattana, M Laowansiri, T Liao, R Kupwiwat, …, S Abe. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection. Biomed. Pharmacother. 2023; 168, 115793.
S Srisakul, DL Wannigama, PG Higgins, C Hurst, S Abe, P Hongsing, T Saethang, S Luk-In, T Liao, N Kueakulpattana, AMS Shein, L Gan, R Kupwiwat, C Tanasatitchai, P Wapeesittipan, P Phattharapornjaroen, VN Badavath, A Leelahavanichkul and T Chatsuwan. Overcoming addition of phosphoethanolamine to lipid A mediated colistin resistance in Acinetobacter baumannii clinical isolates with colistin-sulbactam combination therapy. Sci. Rep. 2022; 12, 11390.
AMS Shein, DL Wannigama, PG Higgins, C Hurst, S Abe, P Hongsing, N Chantaravisoot, T Saethang, S Luk-In, T Liao, S Nilgate, U Rirerm, N Kueakulpattana, S Srisakul, A Aryukarn, M Laowansiri, LY Hao, M Yonpiam, NKD Ragupathi, T Techawiwattanaboon, N Ngamwongsatit, M Amarasiri, P Ounjai, R Kupwiwat, P Phattharapornjaroen, VN Badavath, A Leelahavanichkul, A Kicic and T Chatsuwan. High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy. Sci. Rep. 2022; 12, 12939.
S Luk-In, T Chatsuwan, N Kueakulpattana, U Rirerm, DL Wannigama, R Plongla, R Lawung, C Pulsrikarn, S Chantaroj, P Chaichana, N Saksaengsopa, T Shanthachol, M Techapornroong, S Chayangsu and W Kulwichit. Occurrence of mcr-mediated colistin resistance in Salmonella clinical isolates in Thailand. Sci. Rep. 2021; 11, 14170.
U Singkham-In, PG Higgins, DL Wannigama, P Hongsing and T Chatsuwan. Rescued chlorhexidine activity by resveratrol against carbapenem-resistant Acinetobacter baumannii via down-regulation of AdeB efflux pump. Plos One 2020; 15, e0243082.
P Phuengmaung, P Somparn, W Panpetch, U Singkham-In, DL Wannigama, T Chatsuwan and A Leelahavanichkul. Coexistence of Pseudomonas aeruginosa with Candida albicans enhances biofilm thickness through alginate-related extracellular matrix but is attenuated by N-acetyl-l-cysteine. Front. Cell. Infec. Microbiol. 2020; 10, 594336.
DL Wannigama, C Hurst, L Pearson, T Saethang, U Singkham-In, S Luk-In, RJ Storer and T Chatsuwan. Simple fluorometric-based assay of antibiotic effectiveness for Acinetobacter baumannii biofilms. Sci. Rep. 2019; 9, 6300.
DL Wannigama, R Dwivedi and A Zahraei-Ramazani. Prevalence and antibiotic resistance of gram-negative pathogenic bacteria species isolated from Periplaneta americana and Blattella germanica in Varanasi, India. J. Arthropod Borne Dis. 2014; 8, 10-20.
AMS Shein, P Hongsing, S Abe, S Luk-In, NKD Ragupathi, DL Wannigama and T Chatsuwan. Will there ever be cure for chronic, life-changing Colistin-resistant Klebsiella pneumoniae in urinary tract infection? Front. Med. 2021; 8, 806849.
W Yu, J Zhang, J Tong, L Zhang, Y Zhan, Y Huang and Y Qiu. In vitro antimicrobial activity of fosfomycin, vancomycin and daptomycin alone, and in combination, against linezolid-resistant Enterococcus faecalis. Infect. Dis. Ther. 2020; 9, 927-34.
L Herrera-Hidalgo, B Fernández-Rubio, R Luque-Márquez, LE López-Cortés, MV Gil-Navarro and AD Alarcón. Treatment of Enterococcus faecalis infective endocarditis: A continuing challenge. Antibiotics 2023; 12, 704.
P Danneels, JF Hamel, L Picard, S Rezig, P Martinet, A Lorleac’h, JP Talarmin, R Buzelé, T Guimard, GL Moal, J Brochard-Libois, A Beaudron, J Letheulle, C Codde, R Chenouard, D Boutoille, A Lemaignen, L Bernard, V Cattoir, V Dubée and EFEMER study group. Impact of Enterococcus faecalis endocarditis treatment on risk of relapse. Clin. Infect. Dis. 2022; 76, 281-90.
MAT Blaskovich, AM Kavanagh, AG Elliott, B Zhang, S Ramu, M Amado, GJ Lowe, AO Hinton, DMT Pham, J Zuegg, N Beare, D Quach, MD Sharp, J Pogliano, AP Rogers, D Lyras, L Tan, NP West, DW Crawford, ML Peterson, M Callahan and M Thurn. The antimicrobial potential of cannabidiol. Comm. Biol. 2021; 4, 7.
S Burstein. Cannabidiol (CBD) and its analogs: A review of their effects on inflammation. Bioorg. Med. Chem. 2015; 23, 1377-85.
R Adams, M Hunt and JH Clark. Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp I. J. Am. Chem. Soc. 1940; 62, 196-200.
MA Elsohly and D Slade. Chemical constituents of marijuana: The complex mixture of natural cannabinoids. Life Sci. 2005; 78, 539-48.
JT Dearborn, HR Nelvagal, NR Rensing, K Takahashi, SM Hughes, TM Wishart, JD Cooper, M Wong and MS Sands. Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures. Sci. Rep. 2022; 12, 11286.
R Iseppi, V Brighenti, M Licata, A Lambertini, C Sabia, P Messi, F Pellati and S Benvenuti. Chemical characterization and evaluation of the antibacterial activity of essential oils from fibre-type Cannabis sativa L. (Hemp). Molecules 2019; 24, 2302.
MA Farha, OM El-Halfawy, RT Gale, CR MacNair, LA Carfrae, X Zhang, NG Jentsch, J Magolan and ED Brown. Uncovering the hidden antibiotic potential of Cannabis. ACS Infect. Dis. 2020; 6, 338-46.
DL Wannigama, AMS Shein, C Hurst, PN Monk, P Hongsing, P Phattharapornjaroen, WGF Ditcham, P Ounjai, T Saethang, N Chantaravisoot, P Wapeesittipan, S Luk-In, S Sae-Joo, S Nilgate, U Rirerm, C Tanasatitchai, N Kueakulpattana, M Laowansiri, T Liao, R Kupwiwat, …, S Abe. Ca-EDTA restores the activity of Ceftazidime-Avibactam or Aztreonam against carbapenemase-producing Klebsiella pneumoniae infections. iScience 2023; 26, 107215.
AMS Shein, DL Wannigama, PG Higgins, C Hurst, S Abe, P Hongsing, N Chantaravisoot, T Saethang, S Luk-in, T Liao, S Nilgate, U Rirerm, N Kueakulpattana, M Laowansiri, S Srisakul, N Muhummudaree, T Techawiwattanaboon, L Gan, C Xu, R Kupwiwat, …, T Chatsuwan. Novel colistin-EDTA combination for successful eradication of colistin-resistant Klebsiella pneumoniae catheter-related biofilm infections. Sci. Rep. 2021; 11, 21676.
DL Wannigama, C Hurst, P Hongsing, L Pearson, T Saethang, N Chantaravisoot, U Singkham-In, S Luk-In, RJ Storer and T Chatsuwan. A rapid and simple method for routine determination of antibiotic sensitivity to biofilm populations of Pseudomonas aeruginosa. Ann. Clin. Microbiol. Antimicrobials 2020; 19, 8.
The European Committee for Antimicrobial Susceptibility Testing, Available at: https://www.eucast.org/clinical_breakpoints, accessed March 2024.
Clinical and Laboratory Standards Institute, Available at: https://clsi.org/standards/products/microbiology/
documents/m100/, accessed March 2024.
GA O’Toole. Microtiter dish biofilm formation assay. J. Vis. Exp. 2011; 47, 2437.
C Gentry-Weeks, M Estay, C Loui and D Baker. Intravenous mouse infection model for studying the pathology of Enterococcus faecalis infections. Infect. Immun. 2003; 71, 1434-41.
The R Project for Statistical Computing, Available at: https://www.r-project.org/, accessed March 2024.
MA Khalil, JA Alorabi, LM Al-Otaibi, SS Ali and SE Elsilk. Antibiotic resistance and biofilm formation in enterococcus spp. isolated from urinary tract infections. Pathogens 2022; 12, 34.
S Deiana, A Watanabe, Y Yamasaki, N Amada, M Arthur, S Fleming, H Woodcock, P Dorward, B Pigliacampo, S Close, B Platt and G Riedel. Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour. Psychopharmacology 2012; 219, 859-73.
SA Varvel, JL Wiley, R Yang, DT Bridgen, K Long, AH Lichtman and BR Martin. Interactions between THC and cannabidiol in mouse models of cannabinoid activity. Psychopharmacology 2006; 186, 226-34.
EF Kong, C Tsui, S Kucharíková, D Andes, DP Van and MA Jabra-Rizk. Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. mBio 2016; 7, e01365-16.
L Tang, A Schramm, TR Neu, NP Revsbech and RL Meyer. Extracellular DNA in adhesion and biofilm formation of four environmental isolates: A quantitative study. FEMS Microbiol. Ecol. 2013; 86, 394-403.
BM Peters, ES Ovchinnikova, BP Krom, LM Schlecht, H Zhou, LL Hoyer, HJ Busscher, HCVD Mei, MA Jabra-Rizk and ME Shirtliff. Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p. Microbiology 2012; 158, 2975-86.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
